Skip to content

Vericel VCEL Payments to Acquire Short-Term Investments

Payments to Acquire Short-Term Investments at other companies

LeMaitre Vascular logo
LeMaitre VascularLMAT

Other financials

Income statement

See full
Revenue$68.4M+30.1%
Gross profit$49.3M+35.8%
Operating income-$8.1M+37.0%
Net income-$6.3M+44.0%
EPS (diluted)-$0.12+47.8%

Balance sheet

See full
Cash & equivalents$109.3M+37.1%
Total debt$95.0M-4.6%
Total equity$356.2M+20.6%
Total assets$485.6M+14.4%

Cash flow

See full
Operating cash flow$16.4M+148%
CapEx$1.3M-91.2%
Free cash flow$15.1M+299%

Valuation

See full
Market cap$2.13B-26.8%

Profitability

See full
Gross margin74.8%+2.3pp
Operating margin5.4%+4.6pp
Net margin7.3%+6.1pp
FCF margin16.3%

Returns & leverage

See full
Return on equity6.6%+5.5pp
Debt / equity0.3×-0.1×
Current ratio5.2×+0.2×

Where this comes from

Reported directly by Vericel in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireShortTermInvestments.

The official record: Vericel’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vericel's payments to acquire short-term investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vericel's payments to acquire short-term investments?
Vericel (VCEL) reported payments to acquire short-term investments of $17.19M in Q1 2026.
How has Vericel's payments to acquire short-term investments changed year-over-year?
Vericel's payments to acquire short-term investments increased by 28.0% year-over-year, from $13.43M to $17.19M.
What is the long-term trend for Vericel's payments to acquire short-term investments?
Over 4 years (2021 to 2025), Vericel's payments to acquire short-term investments has grown at a 4.8% compound annual growth rate (CAGR), from $60.02M to $72.37M.